JP2022500418A5 - - Google Patents
Info
- Publication number
- JP2022500418A5 JP2022500418A5 JP2021513958A JP2021513958A JP2022500418A5 JP 2022500418 A5 JP2022500418 A5 JP 2022500418A5 JP 2021513958 A JP2021513958 A JP 2021513958A JP 2021513958 A JP2021513958 A JP 2021513958A JP 2022500418 A5 JP2022500418 A5 JP 2022500418A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- phenyl
- deuteroalkyl
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862730602P | 2018-09-13 | 2018-09-13 | |
| US62/730,602 | 2018-09-13 | ||
| PCT/US2019/050719 WO2020056072A1 (en) | 2018-09-13 | 2019-09-12 | 1h-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (ripk1) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022500418A JP2022500418A (ja) | 2022-01-04 |
| JP2022500418A5 true JP2022500418A5 (cg-RX-API-DMAC7.html) | 2022-09-05 |
| JP7599411B2 JP7599411B2 (ja) | 2024-12-13 |
Family
ID=68073171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021513958A Active JP7599411B2 (ja) | 2018-09-13 | 2019-09-12 | 受容体相互作用タンパク質キナーゼ1阻害剤(ripk1)としての1h-インダゾールカルボキサミド |
Country Status (14)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111566103B (zh) | 2017-10-30 | 2023-06-23 | 百时美施贵宝公司 | 作为激酶抑制剂的氨基咪唑并吡嗪 |
| US11618753B2 (en) | 2018-01-26 | 2023-04-04 | Bristol-Myers Squibb Company | Aminopyrrolotriazines as kinase inhibitors |
| KR102793119B1 (ko) | 2018-09-13 | 2025-04-07 | 브리스톨-마이어스 스큅 컴퍼니 | 키나제 억제제로서의 인다졸 카르복스아미드 |
| US12275721B2 (en) | 2019-10-03 | 2025-04-15 | Bristol-Myers Squibb Company | Indazole carboxamides as kinase inhibitors |
| US11744824B2 (en) * | 2020-09-15 | 2023-09-05 | 1ST Biotherapeutics, Inc. | 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds |
| AR123793A1 (es) | 2020-10-19 | 2023-01-11 | Bristol Myers Squibb Co | Compuestos de triazolopiridinilo como inhibidores de quinasas |
| WO2025106362A1 (en) * | 2023-11-16 | 2025-05-22 | Merck Sharp & Dohme Llc | Ripk1 inhibitors and methods of use |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7872014B2 (en) | 2003-07-23 | 2011-01-18 | Exelixis, Inc. | Anaplastic lymphoma kinase modulators and methods of use |
| JP2008525464A (ja) | 2004-12-22 | 2008-07-17 | メモリー・ファーマシューティカルズ・コーポレイション | α−7ニコチン性受容体リガンド並びにその製造及び使用 |
| NZ573735A (en) | 2006-05-19 | 2011-10-28 | Abbott Lab | Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives |
| KR101061599B1 (ko) | 2008-12-05 | 2011-09-02 | 한국과학기술연구원 | 비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물 |
| WO2010068287A2 (en) | 2008-12-11 | 2010-06-17 | Angion Biomedica Corp. | Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| ES2458872T3 (es) | 2009-04-30 | 2014-05-07 | Novartis Ag | Derivados de imidazol y su uso como moduladores de quinasas dependientes de ciclina |
| US8455516B2 (en) | 2010-01-15 | 2013-06-04 | Touro University | HIV-1 fusion inhibitors and methods |
| KR20130077390A (ko) * | 2011-12-29 | 2013-07-09 | 제이더블유중외제약 주식회사 | 단백질 키나아제 저해활성을 가지는 6-아미노-3-카복스아미도인다졸 유도체 |
| EA024939B1 (ru) | 2012-02-21 | 2016-11-30 | Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. | 1h-индазол-3-карбоксамидные соединения в качестве ингибиторов гликогенсинтазы киназы 3-бета |
| WO2013124169A1 (en) | 2012-02-21 | 2013-08-29 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors |
| US9783573B2 (en) | 2012-09-18 | 2017-10-10 | Bristol-Myers Squibb Company | IAP antagonists |
| CN104781251B (zh) * | 2012-11-08 | 2016-12-14 | 百时美施贵宝公司 | 可作为激酶调节剂的经双环杂环取代的吡啶基化合物 |
| BR112016021626A2 (pt) | 2014-03-20 | 2018-05-15 | Samumed, Llc | indazol-3-carboxamidas 5-substituídas e preparação e uso das mesmas |
| US10933068B2 (en) | 2016-05-26 | 2021-03-02 | Sonic Master Limited | Modulators of DUX4 for regulation of muscle function |
| LT3580220T (lt) | 2017-02-13 | 2021-12-27 | Bristol-Myers Squibb Company | Aminotriazolopiridinai, kaip kinazės inhibitoriai |
| CN111566103B (zh) | 2017-10-30 | 2023-06-23 | 百时美施贵宝公司 | 作为激酶抑制剂的氨基咪唑并吡嗪 |
| US11618753B2 (en) | 2018-01-26 | 2023-04-04 | Bristol-Myers Squibb Company | Aminopyrrolotriazines as kinase inhibitors |
| KR102793119B1 (ko) | 2018-09-13 | 2025-04-07 | 브리스톨-마이어스 스큅 컴퍼니 | 키나제 억제제로서의 인다졸 카르복스아미드 |
| US12275721B2 (en) | 2019-10-03 | 2025-04-15 | Bristol-Myers Squibb Company | Indazole carboxamides as kinase inhibitors |
-
2019
- 2019-09-12 KR KR1020217010498A patent/KR102906523B1/ko active Active
- 2019-09-12 SG SG11202102405YA patent/SG11202102405YA/en unknown
- 2019-09-12 ES ES19779240T patent/ES2936481T3/es active Active
- 2019-09-12 EP EP19779240.1A patent/EP3849968B1/en active Active
- 2019-09-12 CN CN201980059445.8A patent/CN112673000B/zh active Active
- 2019-09-12 EA EA202190718A patent/EA202190718A1/ru unknown
- 2019-09-12 WO PCT/US2019/050719 patent/WO2020056072A1/en not_active Ceased
- 2019-09-12 CA CA3112735A patent/CA3112735A1/en active Pending
- 2019-09-12 MX MX2021002509A patent/MX2021002509A/es unknown
- 2019-09-12 AU AU2019337612A patent/AU2019337612A1/en not_active Abandoned
- 2019-09-12 JP JP2021513958A patent/JP7599411B2/ja active Active
- 2019-09-12 US US17/274,220 patent/US12172975B2/en active Active
- 2019-09-12 BR BR112021004385-3A patent/BR112021004385A2/pt not_active Application Discontinuation
-
2021
- 2021-03-09 IL IL281370A patent/IL281370A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017283769B2 (en) | Compounds and compositions for inhibiting the activity of SHP2 | |
| JP2017511815A5 (cg-RX-API-DMAC7.html) | ||
| JP6196156B2 (ja) | 過剰増殖性障害および血管新生に関連する疾患の治療のために有用なアミノアルコール置換2,3−ジヒドロイミダゾ[1,2−c]キナゾリン誘導体 | |
| ES2660831T3 (es) | Derivados de imidazol condensados útiles como inhibidores de IDO | |
| JP2019512505A5 (cg-RX-API-DMAC7.html) | ||
| RU2376292C2 (ru) | Гамк-ергические модуляторы | |
| JP2022501334A5 (cg-RX-API-DMAC7.html) | ||
| ES2639402T3 (es) | 2,3-dihidroimidazo[1,2-c]quinolinas sustituidas con arilaminoalcohol | |
| WO2019101642A1 (en) | Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides | |
| RU2012117398A (ru) | Бензоксазепиновые ингибиторы pi3 и способы применения | |
| RU2012156940A (ru) | Лекарственные средства, индуцирующие апоптоз, для лечения рака и иммунных и аутоиммунных заболеваний | |
| RU2010110036A (ru) | Производные пиперидина в качестве агонистов мускариновых рецепторов | |
| RU2014115476A (ru) | Производные пиразоло[4, 3-с]птридина в качестве ингибиторов киназ | |
| RU2015106434A (ru) | Производные типа азаиндазола или диазаиндазола для лечения боли | |
| JP2008526999A5 (cg-RX-API-DMAC7.html) | ||
| CN107108554B (zh) | 作为midh1抑制剂用于治疗肿瘤的1-环己基-2-苯基氨基苯并咪唑 | |
| EA037517B1 (ru) | Антипролиферативные соединения и их фармацевтические композиции и применения | |
| RU2012130929A (ru) | Гетероциклические соединения в качестве ингибиторов янус-киназы | |
| RU2010136721A (ru) | Агонисты мускариновых рецепторов, композиции, способы лечения ими и способы их изготовления | |
| CN107108522A (zh) | 作为mIDH1抑制剂的苯并咪唑‑2‑胺 | |
| JP2020520957A5 (cg-RX-API-DMAC7.html) | ||
| BR112017013148A2 (pt) | pirazolopiridinaminas como inibidores mknk1 e mknk2 | |
| RU2008125040A (ru) | ПРОИЗВОДНЫЕ АРИЛ-ИЗОКСАЗОЛ-4-ИЛ-ИМИДАЗО[1.5-a]ПИРИДИНА | |
| JP2024533787A5 (cg-RX-API-DMAC7.html) | ||
| JP2013542237A (ja) | アルコキシ−置換2,3−ジヒドロイミダゾ[1,2−c]キナゾリン |